Related Experiment Videos

Evaluation of eosin-fluorescence in the diagnosis of sudden cardiac death

P Saukko1, B Knight

  • 1Department of Forensic Medicine, University of Oulu, Finland.

Insights

The eosin-fluorescence method shows potential for diagnosing sudden cardiac death (SCD) but is too sensitive and unreliable for medicolegal use due to high false positive rates.

Area of Science:

  • Forensic Pathology
  • Biochemistry

Background:

  • Sudden cardiac death (SCD) diagnosis relies on accurate postmortem analysis.
  • Enzyme histochemical methods like beta-hydroxybutyrate-dehydrogenase (beta-HBDH) are established diagnostic tools.
  • Novel fluorescence methods require validation against established techniques.

Purpose of the Study:

  • To evaluate the diagnostic significance of the eosin-fluorescence method in sudden cardiac death.
  • To compare eosin-fluorescence with beta-hydroxybutyrate-dehydrogenase (beta-HBDH) and hyperchromasia.
  • To assess the impact of postmortem autolysis on fluorescence findings.

Main Methods:

  • Analyzed 568 heart samples from sudden cardiac death (SCD) and control cases.
  • Compared eosin-fluorescence with beta-HBDH enzyme histochemistry and hyperchromasia.
  • Investigated autolysis effects at +4°C and +22°C.

Main Results:

  • Yellow-fluorescence and hyperchromasia increased significantly from controls to beta-HBDH-positive SCD cases (P < 0.001).
  • Fluorescence changes did not correlate with beta-HBDH activity or hyperchromasia patterns.
  • Postmortem autolysis did not significantly alter fluorescence, but 78% false positives occurred in controls.

Conclusions:

  • Eosin-fluorescence shows a significant difference between SCD and control groups.
  • The method's high false positive rate makes it unreliable for medicolegal diagnosis of SCD.
  • Further refinement is needed to improve specificity and reliability.

Related Concept Videos